Literature DB >> 28912020

Intestinal Dysbiosis Featuring Abundance of Ruminococcus gnavus Associates With Allergic Diseases in Infants.

Huey-Huey Chua1, Hung-Chieh Chou1, Ya-Ling Tung1, Bor-Luen Chiang2, Chien-Chia Liao3, Hong-Hsing Liu4, Yen-Hsuan Ni5.   

Abstract

BACKGROUND & AIMS: Dysbiosis of the intestinal microbiota has been associated with development of allergies in infants. However, it is not clear what microbes might contribute to this process. We investigated what microbe(s) might be involved in analyses of infant twins and mice.
METHODS: We studied fecal specimens prospectively in a twin cohort (n = 30) and age-matched singletons (n = 14) born at National Taiwan University Children's Hospital, Taipei, Taiwan, from April 2011 to March 2013. Clinical parameters (gestational age, birth body weight, mode of delivery and feeding, immunizations, and medical events) were recorded. Fecal samples were collected beginning immediately after birth and for 1 year; the children were followed until 3 years of age and allergic symptoms (repetitive and continuous for at least 6 months) were noted. A skin prick test was used to ascertain atopy. Bacterial communities in fecal samples were profiled by 16S ribosomal RNA-based polymerase chain reaction-temporal temperature gradient gel electrophoresis and next-generation sequencing. BALB/c mice without and with ovalbumin sensitization/challenge were infected with candidate bacteria by oral gauge intragastric intubation. Fecal, serum, lung, and colon tissue samples were collected from mice and analyzed for mechanisms of allergy development.
RESULTS: During the investigation period, 20 children (45.5%) developed allergic diseases, including respiratory (allergic rhinitis and asthma) and skin (atopic dermatitis and eczema) allergies. Lachnospiraceae were detected at significantly higher frequency in allergic infants than nonallergic infants (P < .004); the high fecal count of Lachnospiraceae in allergic subjects appeared at 2 months of age and persisted until 12 months of age. The enrichment of Lachnospiraceae in allergic infants was attributed to the overgrowth of Ruminococcus gnavus, which tended to have a low frequency in nonallergic subjects (P = .0004). Increased R gnavus was observed before the onset of allergic manifestations, and was associated with respiratory allergies (P < .002) or respiratory allergies coexistent with atopic eczema (P < .001). In mice, endogenous R gnavus grew rapidly after sensitization and challenge with ovalbumin. Mice gavaged with purified R gnavus developed airway hyper-responsiveness and had histologic evidence of airway inflammation (asthma). Expansion of R gnavus in mice stimulated secretion of cytokines (interleukin [IL] 25, IL33, and thymic stromal lymphopoietin) by colon tissues, which activated type 2 innate lymphoid cells and dendritic cells to promote differentiation of T-helper 2 cells and production of their cytokines (IL4, IL5, and IL13). This led to infiltration of the colon and lung parenchyma by eosinophils and mast cells.
CONCLUSIONS: In a study of a twin cohort (some infants with, some without allergies), we associated development of allergies, particularly respiratory allergies, with increased fecal abundance of R gnavus. Mice fed R gnavus developed airway inflammation, characterized by expansion of T-helper 2 cells in the colon and lung, and infiltration of colon and lung parenchyma by eosinophils and mast cells.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelium-Derived Cytokines; ILC2; Immune Regulation; TSLP

Mesh:

Year:  2017        PMID: 28912020     DOI: 10.1053/j.gastro.2017.09.006

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  50 in total

1.  Compositional analyses reveal correlations between taxon-level gut bacterial abundance and peripheral T cell marker expression in African infants.

Authors:  Bryan P Brown; Heather B Jaspan
Journal:  Gut Microbes       Date:  2019-07-26

2.  B cell superantigens in the human intestinal microbiota.

Authors:  Jeffrey J Bunker; Christoph Drees; Andrea R Watson; Catherine H Plunkett; Cathryn R Nagler; Olaf Schneewind; A Murat Eren; Albert Bendelac
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

3.  Lactobacillus reuteri DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites.

Authors:  Yuying Liu; Xiangjun Tian; Baokun He; Thomas K Hoang; Christopher M Taylor; Eugene Blanchard; Jasmin Freeborn; Sinyoung Park; Meng Luo; Jacob Couturier; Dat Q Tran; Stefan Roos; Guoyao Wu; J Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-04       Impact factor: 4.052

Review 4.  The Ruminococci: key symbionts of the gut ecosystem.

Authors:  Alex J La Reau; Garret Suen
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

Review 5.  Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?

Authors:  Anuradha Ray; Matthew Camiolo; Anne Fitzpatrick; Marc Gauthier; Sally E Wenzel
Journal:  Physiol Rev       Date:  2020-01-09       Impact factor: 37.312

Review 6.  Systemic Lupus Erythematosus and dysbiosis in the microbiome: cause or effect or both?

Authors:  Gregg J Silverman; Doua F Azzouz; Alexander V Alekseyenko
Journal:  Curr Opin Immunol       Date:  2019-10-04       Impact factor: 7.486

7.  Safety and efficacy of probiotic administration to preterm infants: ten common questions.

Authors:  Mark A Underwood; Erin Umberger; Ravi M Patel
Journal:  Pediatr Res       Date:  2020-08       Impact factor: 3.756

8.  Paneth Cell-Derived Lysozyme Defines the Composition of Mucolytic Microbiota and the Inflammatory Tone of the Intestine.

Authors:  Shiyan Yu; Iyshwarya Balasubramanian; Daniel Laubitz; Kevin Tong; Sheila Bandyopadhyay; Xiang Lin; Juan Flores; Rajbir Singh; Yue Liu; Carlos Macazana; Yanlin Zhao; Fabienne Béguet-Crespel; Karuna Patil; Monica T Midura-Kiela; Daniel Wang; George S Yap; Ronaldo P Ferraris; Zhi Wei; Edward M Bonder; Max M Häggblom; Lanjing Zhang; Veronique Douard; Michael P Verzi; Ken Cadwell; Pawel R Kiela; Nan Gao
Journal:  Immunity       Date:  2020-08-18       Impact factor: 31.745

9.  Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension.

Authors:  Seungbum Kim; Katya Rigatto; Marcelo B Gazzana; Marli M Knorst; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Hypertension       Date:  2020-02-24       Impact factor: 10.190

10.  Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension.

Authors:  Ravindra K Sharma; Aline C Oliveira; Tao Yang; Marianthi M Karas; Jing Li; Gilberto O Lobaton; Victor P Aquino; Iñaki Robles-Vera; Annette D de Kloet; Eric G Krause; Andrew J Bryant; Amrisha Verma; Qiuhong Li; Elaine M Richards; Mohan K Raizada
Journal:  Hypertension       Date:  2020-05-18       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.